T. Yavuz Et Al. , "Pyrrolidine dithiocarbamate attenuates the development of monocrotaline-induced pulmonary arterial hypertension," PATHOLOGY RESEARCH AND PRACTICE , vol.209, no.5, pp.302-308, 2013
Yavuz, T. Et Al. 2013. Pyrrolidine dithiocarbamate attenuates the development of monocrotaline-induced pulmonary arterial hypertension. PATHOLOGY RESEARCH AND PRACTICE , vol.209, no.5 , 302-308.
Yavuz, T., Uzun, O., Macit, A., Comunoglu, C., Yavuz, O., SILAN, C., ... Yüksel, H.(2013). Pyrrolidine dithiocarbamate attenuates the development of monocrotaline-induced pulmonary arterial hypertension. PATHOLOGY RESEARCH AND PRACTICE , vol.209, no.5, 302-308.
Yavuz, Taner Et Al. "Pyrrolidine dithiocarbamate attenuates the development of monocrotaline-induced pulmonary arterial hypertension," PATHOLOGY RESEARCH AND PRACTICE , vol.209, no.5, 302-308, 2013
Yavuz, Taner Et Al. "Pyrrolidine dithiocarbamate attenuates the development of monocrotaline-induced pulmonary arterial hypertension." PATHOLOGY RESEARCH AND PRACTICE , vol.209, no.5, pp.302-308, 2013
Yavuz, T. Et Al. (2013) . "Pyrrolidine dithiocarbamate attenuates the development of monocrotaline-induced pulmonary arterial hypertension." PATHOLOGY RESEARCH AND PRACTICE , vol.209, no.5, pp.302-308.
@article{article, author={Taner Yavuz Et Al. }, title={Pyrrolidine dithiocarbamate attenuates the development of monocrotaline-induced pulmonary arterial hypertension}, journal={PATHOLOGY RESEARCH AND PRACTICE}, year=2013, pages={302-308} }